<VariationArchive RecordType="classified" VariationID="157555" VariationName="NM_015559.3(SETBP1):c.2464del (p.Ile822fs)" VariationType="Deletion" Accession="VCV000157555" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2022-04-11" MostRecentSubmission="2022-04-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="167418" VariationID="157555">
      <GeneList>
        <Gene Symbol="SETBP1" FullName="SET binding protein 1" GeneID="26040" HGNC_ID="HGNC:15573" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q12.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="44680073" stop="45068510" display_start="44680073" display_stop="45068510" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="42260137" stop="42648474" display_start="42260137" display_stop="42648474" Strand="+" />
          </Location>
          <OMIM>611060</OMIM>
          <Haploinsufficiency last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SETBP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SETBP1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015559.3(SETBP1):c.2464del (p.Ile822fs)</Name>
      <CanonicalSPDI>NC_000018.10:44951802:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q12.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="44951803" stop="44951803" display_start="44951803" display_stop="44951803" variantLength="1" positionVCF="44951802" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="42531769" stop="42531769" display_start="42531769" display_stop="42531769" variantLength="1" positionVCF="42531767" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>I822fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1150" sequenceAccession="LRG_1150">
            <Expression>LRG_1150:g.276632del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1150t1" sequenceAccession="LRG_1150t1">
            <Expression>LRG_1150t1:c.2464del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1150p1" sequenceAccession="LRG_1150p1" change="p.Ile822fs">
            <Expression>LRG_1150p1:p.Ile822fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.44951804del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.44951804del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.42531769del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.42531769del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027527.2" sequenceAccession="NG_027527" sequenceVersion="2" change="g.276632del">
            <Expression>NG_027527.2:g.276632del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015559.3" sequenceAccession="NM_015559" sequenceVersion="3" change="c.2464del" MANESelect="true">
            <Expression>NM_015559.3:c.2464del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056374.2" sequenceAccession="NP_056374" sequenceVersion="2" change="p.Ile822fs">
            <Expression>NP_056374.2:p.Ile822fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA170958" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="611060.0006" DB="OMIM" />
        <XRef Type="rs" ID="606231269" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015559.3(SETBP1):c.2464del (p.Ile822fs) AND Intellectual disability, autosomal dominant 29" Accession="RCV000144900" Version="4">
        <ClassifiedConditionList TraitSetID="19853">
          <ClassifiedCondition DB="MedGen" ID="C4015141">Intellectual disability, autosomal dominant 29</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2014-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2014-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-04-11" MostRecentSubmission="2022-04-11">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25217958</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="19853" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32123" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29</ElementValue>
                <XRef Type="MIM" ID="616078" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="611060.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Intellectual disability, autosomal dominant 29</ElementValue>
                <XRef ID="MONDO:0014482" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRD29</ElementValue>
                <XRef Type="MIM" ID="616078" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">SETBP1 haploinsufficiency disorder (SETBP1-HD) is characterized by hypotonia and mild motor developmental delay; intellectual abilities ranging from normal to severe disability; speech and language disorder; behavioral problems (most commonly attention/concentration deficits and hyperactivity, impulsivity), and refractive errors and strabismus. Typically children with SETBP1-HD whose intellect is in the normal or borderline range (IQ 80-90) were diagnosed following genetic testing for behavioral problems and/or severe speech and language disorders (respectively: the inability to produce sounds in words correctly, and deficits in the understanding and/or expression of words and sentences). To date, 47 individuals with SETBP1-HD have been reported.</Attribute>
                <XRef ID="NBK575336" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13379" />
                <XRef ID="13379" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34807554</ID>
                <ID Source="BookShelf">NBK575336</ID>
              </Citation>
              <XRef ID="436151" DB="Orphanet" />
              <XRef ID="C4015141" DB="MedGen" />
              <XRef ID="MONDO:0014482" DB="MONDO" />
              <XRef Type="MIM" ID="616078" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="339263" SubmissionDate="2022-04-06" DateLastUpdated="2022-04-11" DateCreated="2014-11-09">
        <ClinVarSubmissionID localKey="611060.0006_INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29" title="SETBP1, 1-BP DEL_INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29" />
        <ClinVarAccession Accession="SCV000191902" DateUpdated="2022-04-11" DateCreated="2014-11-09" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 14-year-old boy with a normal IQ but with speech delay, motor delay, and dysmorphic facial features (MRD29; 616078), Coe et al. (2014) identified a heterozygous de novo frameshift mutation in the SETBP1 gene, a 1-bp deletion at g.42531769 (GRCh37) resulting in an ile822-to-tyr (I822Y) substitution and a frameshift with a stop codon following 13 amino acids (Ile822TyrfsTer13). The patient's IQ was 76, which is in the borderline range, but was 'disharmonic.' The patient had speech impairment, with first words at 18 months but almost no speak until age 4 years. At age 14 he spoke but was hard to understand, with words in the wrong order and difficulty finding words. Growth parameters were within normal limits. Brain MRI was normal.</Attribute>
              <Citation>
                <ID Source="PubMed">25217958</ID>
              </Citation>
              <XRef DB="OMIM" ID="616078" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SETBP1" />
          </GeneList>
          <Name>SETBP1, 1-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611060.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="339263" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 29" MappingRef="Preferred">
        <MedGen CUI="C4015141" Name="Intellectual disability, autosomal dominant 29" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

